Bumetanide is a diuretic medication used to treat fluid retention in conditions such as heart failure and kidney disease. However, during its production, impurities can be formed which can affect the safety and efficacy of the drug. These impurities may include residual solvents, by-products of synthesis, and degradation products. It is important to monitor and control these impurities to ensure the quality and safety of the final product.